Multi-omics Uncovering Different Faces of Clear Cell Ovarian Cancer Available to Purchase

The diagnosis of clear cell ovarian cancer relies on expert histopathology review. Further characterization from deep genomic and transcriptomic analyses can identify different subgroups. International collaboration is required to define the clinical impact and therapy opportunities in these specific subclassifications.

See related article by Bolton et al., p. 4947